APOL1 kidney risk variants in glomerular diseases modeled in transgenic mice
T. Yoshida, K. Z. Latt, B. A. Santo, S. Shrivastav, Y. Zhao, P. Fenaroli, J.-Y. Chung, S. M. Hewitt, V. M. Tutino, P. Sarder, A. Z. Rosenberg, C. A. Winkler, J. B. Kopp
This paper uses two transgenic mouse models to study APOL1 risk variants' effects on glomerular disease, identifying shared and distinct transcriptional changes in podocytes.
bioRxiv · Mar 27, 2023Pathology